✦ LIBER ✦

Cilengitide shows potential in malignant glioma

Book ID: 120846936
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715890-00013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2-5A-linked telomerase antisense oligonu

2-5A-linked telomerase antisense oligonucleotide shows potential in malignant glioma

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Anti-tenascin monoclonal antibody (mAb)

Anti-tenascin monoclonal antibody (mAb) 81C6-I-131 shows potential in malignant glioma,

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Catumaxomab shows potential in malignant

Catumaxomab shows potential in malignant ascites

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Cystemustine shows potential in dissemin

Cystemustine shows potential in disseminated malignant melanoma

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Interleukin-13 PE38QQR shows promise in

Interleukin-13 PE38QQR shows promise in treatment of recurrent malignant glioma

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Angiogenesis in malignant gliomas

✍ Dr. Karl H. Plate; Werner Risau 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 993 KB

## Abstract One event that accompanies glioma progression is the upregulation of angiogenesis. Low‐grade gliomas are moderately vascularized tumors whereas high‐grade gliomas show prominent microvascular proliferations and areas of high vascular density. To analyze the molecular mechanisms underlyi